Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Video prep may ease needle fear in kids with leukemia

NCT ID NCT07602621

Symptom relief Sponsor: Ege University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether showing a short educational video before a subcutaneous injection can reduce anxiety and crying in children aged 3 to 6 with leukemia. Sixty children will be split into three groups: video plus emotional preparation, emotional preparation alone, or standard care. Researchers will measure emotional expression, procedure time, and crying duration.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Video-assisted structured emotional preparation
What this could lead to
If it works, this could offer a simple, low-cost way to reduce fear and distress in young children with leukemia during needle procedures.
What could go wrong
This is a small, early-stage trial with only 60 children, so results may not apply broadly. The intervention is behavioral, not a drug, so the effect may be modest.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 60 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jul 2026

An estimate. Start dates often move.

Expected to finish

Jul 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

3 to 6 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * The child must be between the ages of 3 and 6, * The child must be receiving inpatient treatment at the Pediatric Hematology Clinic, * The child must be scheduled to undergo a subcutaneous procedure related to a leukemia diagnosis * The child and parent must agree to participate in the study and provide written informed consent, * The child and parent must be able to communicate in basic Turkish, * At least one parent (mother or father) must be present with the child during the procedure. Exclusion Criteria: * Development of an acute or unstable clinical condition * The child's discharge or continuation of treatment on an outpatient basis * A single SC procedure performed based on the child's clinical condition * The child has received sedation or a medication causing confusion prior to the procedure * The child has severe vision or hearing problems that prevent video viewing or a structured emotional preparation interview * Another interventional procedure is scheduled for the same day * Withdrawal of informed consent by the child or parent during the process * Difficulty adhering to the study protocol (e.g., discontinuing the procedure or refusing the procedure). * If communication or cooperation issues prevent the completion of research data, the case will be excluded from the study.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Leukemia are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

childhood leukemia leukemia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Pediatric leukemia

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.